{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:04:38Z","timestamp":1788350678880,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470630"],"award-info":[{"award-number":["81470630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperoxia-mediated inhibition of vascular endothelial growth factor (VEGF) in the retina is the main cause of impeded angiogenesis during phase I retinopathy of prematurity (ROP). Human retinal angiogenesis involves the proliferation, migration and vessel-forming ability of microvascular endothelial cells. Previous studies have confirmed that BTB and CNC homology l (BACH1) can inhibit VEGF and angiogenesis, while haem can specifically degrade BACH1. However, the effect of haem on endothelial cells and ROP remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this report, we established a model of the relative hyperoxia of phase I ROP by subjecting human microvascular endothelial cells (HMEC-1) to 40% hyperoxia. Haem was added, and its effects on the growth and viability of HMEC-1 cells were evaluated. Cell counting kit 8 (CCK8) and 5-ethynyl-2\u2032-deox-yuridine (EdU) assays were used to detect proliferation, whereas a wound healing assay and Matrigel cultures were used to detect the migration and vessel-forming ability, respectively. Western blot (WB) and immunofluorescence (IF) assays were used to detect the relative protein levels of BACH1 and VEGF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HMEC-1 cells could absorb extracellular haem under normoxic or hyperoxic conditions. The proliferation, migration and angiogenesis abilities of HMEC-1 cells were inhibited under hyperoxia. Moderate levels of haem can promote endothelial cell proliferation, while 20\u2009\u03bcM haem could inhibit BACH1 expression, promote VEGF expression, and relieve the inhibition of proliferation, migration and angiogenesis in HMEC-1 cells induced by hyperoxia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Haem (20\u2009\u03bcM) can relieve hyperoxia-induced inhibition of VEGF activity in HMEC-1 cells by inhibiting BACH1 and may be a potential medicine for overcoming stunted retinal angiogenesis induced by relative hyperoxia in phase I ROP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-021-01866-x","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T07:03:31Z","timestamp":1614236611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Haem relieves hyperoxia-mediated inhibition of HMEC-1 cell proliferation, migration and angiogenesis by inhibiting BACH1 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"Lan","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Rongdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445\u201357.","journal-title":"Lancet."},{"key":"1866_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","volume":"63","author":"S Selvam","year":"2018","unstructured":"Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res. 2018;63:1\u201319.","journal-title":"Prog Retin Eye Res"},{"key":"1866_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","volume":"62","author":"T Chan-Ling","year":"2018","unstructured":"Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77\u2013119.","journal-title":"Prog Retin Eye Res"},{"key":"1866_CR4","first-page":"135","volume":"15","author":"S Cherian","year":"2014","unstructured":"Cherian S, Morris I, Evans J, Kotecha S. Oxygen therapy in preterm infants. Paediatr Respir Rev. 2014;15:135\u201341.","journal-title":"Paediatr Respir Rev"},{"key":"1866_CR5","doi-asserted-by":"crossref","first-page":"1347969","DOI":"10.1155\/2018\/1347969","volume":"2018","author":"X Zhang","year":"2018","unstructured":"Zhang X, Guo J, Wei X, Niu C, Jia M, Li Q, et al. Bach1: function, regulation, and involvement in disease. Oxidative Med Cell Longev. 2018;2018:1347969.","journal-title":"Oxidative Med Cell Longev"},{"key":"1866_CR6","doi-asserted-by":"crossref","first-page":"6234043","DOI":"10.1155\/2016\/6234043","volume":"2016","author":"X Wang","year":"2016","unstructured":"Wang X, Liu J, Jiang L, Wei X, Niu C, Wang R, et al. Bach1 induces endothelial cell apoptosis and cell-cycle arrest through ROS generation. Oxidative Med Cell Longev. 2016;2016:6234043.","journal-title":"Oxidative Med Cell Longev"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCRESAHA.115.306829","volume":"117","author":"L Jiang","year":"2015","unstructured":"Jiang L, Yin M, Wei X, Liu J, Wang X, Niu C, et al. Bach1 represses Wnt\/\u03b2-catenin signaling and angiogenesis. Circ Res. 2015;117:364\u201375.","journal-title":"Circ Res"},{"key":"1866_CR8","doi-asserted-by":"crossref","first-page":"2143875","DOI":"10.1155\/2017\/2143875","volume":"2017","author":"L Jiang","year":"2017","unstructured":"Jiang L, Yin M, Xu J, Jia M, Sun S, Wang X, et al. The transcription factor Bach1 suppresses the developmental angiogenesis of zebrafish. Oxidative Med Cell Longev. 2017;2017:2143875.","journal-title":"Oxidative Med Cell Longev"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","volume":"568","author":"J Lee","year":"2019","unstructured":"Lee J, Yesilkanal AE, Wynne JP, Frankenberger C, Liu J, Yan J, et al. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature. 2019;568:254\u20138.","journal-title":"Nature."},{"key":"1866_CR10","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1128\/MCB.02415-06","volume":"27","author":"Y Zenke-Kawasaki","year":"2007","unstructured":"Zenke-Kawasaki Y, Dohi Y, Katoh Y, Ikura T, Ikura M, Asahara T, et al. Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol. 2007;27:6962\u201371.","journal-title":"Mol Cell Biol"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"17912","DOI":"10.1002\/jcb.29059","volume":"120","author":"L Ai","year":"2019","unstructured":"Ai L, Lin S, Huang C, Gao L, Zhou J, Chen C, et al. Simultaneous interference of SP1 and HIF1\u03b1 retarding the proliferation, migration, and invasion of human microvascular endothelial cells (HMEC-1) under hypoxia. J Cell Biochem. 2019;120:17912\u201325.","journal-title":"J Cell Biochem"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1091\/mbc.E18-04-0228","volume":"29","author":"EE Bastounis","year":"2018","unstructured":"Bastounis EE, Yeh YT, Theriot JA. Matrix stiffness modulates infection of endothelial cells by Listeria monocytogenes via expression of cell surface vimentin. Mol Biol Cell. 2018;29:1571\u201389.","journal-title":"Mol Biol Cell"},{"key":"1866_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/EJA.0000000000000593","volume":"34","author":"C Hafner","year":"2017","unstructured":"Hafner C, Wu J, Soto-Gonzalez L, Kaun C, Stojkovic S, Wojta J, et al. Moderate hyperoxia induces inflammation, apoptosis and necrosis in human umbilical vein endothelial cells: an in-vitro study. Eur J Anaesthesiol. 2017;34:141\u20139.","journal-title":"Eur J Anaesthesiol"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/aas.12646","volume":"60","author":"J Wu","year":"2016","unstructured":"Wu J, Hafner C, Schramel JP, Kaun C, Krychtiuk KA, Wojta J, et al. Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells. Acta Anaesthesiol Scand. 2016;60:492\u2013501.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1007\/s00216-017-0610-5","volume":"409","author":"J Fyrestam","year":"2017","unstructured":"Fyrestam J, \u00d6stman C. Determination of heme in microorganisms using HPLC-MS\/MS and cobalt(III) protoporphyrin IX inhibition of heme acquisition in Escherichia coli. Anal Bioanal Chem. 2017;409:6999\u20137010.","journal-title":"Anal Bioanal Chem"},{"key":"1866_CR16","first-page":"82","volume":"34","author":"O Dogan","year":"2019","unstructured":"Dogan O, Serdar MA, Murat K, Sonmez C, \u0130spir E, Serteser M, et al. A simple method for quantification of five urinary porphyrins, porphobilinogen and 5-aminolevulinic acid, using liquid chromatography tandem mass spectrometry. Indian J Clin Biochem. 2019;34:82\u20138.","journal-title":"Indian J Clin Biochem"},{"key":"1866_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exer.2016.08.005","volume":"151","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Saker S, Amoaku WM. Dexamethasone reverses the effects of high glucose on human retinal endothelial cell permeability and proliferation in vitro. Exp Eye Res. 2016;151:75\u201381.","journal-title":"Exp Eye Res"},{"key":"1866_CR18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s12264-020-00510-w","volume":"36","author":"R Yuan","year":"2020","unstructured":"Yuan R, Yang M, Fan W, Lan J, Zhou YG. Paired immunoglobulin-like receptor B inhibition in m\u00fcller cells promotes neurite regeneration after retinal ganglion cell injury in vitro. Neurosci Bull. 2020;36:972\u201384.","journal-title":"Neurosci Bull"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exer.2015.04.011","volume":"135","author":"M Lulli","year":"2015","unstructured":"Lulli M, Cammalleri M, Fornaciari I, Casini G, Dal MM. Acetyl-11-keto-\u03b2-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Exp Eye Res. 2015;135:67\u201380.","journal-title":"Exp Eye Res"},{"key":"1866_CR20","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1167\/iovs.18-23892","volume":"59","author":"J Song","year":"2018","unstructured":"Song J, Lee K, Park SW, Chung H, Jung D, Na YR, et al. Lactic acid upregulates VEGF expression in macrophages and facilitates choroidal neovascularization. Invest Ophthalmol Vis Sci. 2018;59:3747\u201354.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1866_CR21","doi-asserted-by":"publisher","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","volume":"6","author":"E Zudaire","year":"2011","unstructured":"Zudaire E, Gambardella L, Kurcz C, Vermeren S. A computational tool for quantitative analysis of vascular networks. PLoS One. 2011;6:e27385.","journal-title":"PLoS One"},{"key":"1866_CR22","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1167\/iovs.18-23800","volume":"59","author":"A Arta","year":"2018","unstructured":"Arta A, Eriksen AZ, Melander F, Kempen P, Larsen M, Andresen TL, et al. Endothelial protein C-targeting liposomes show enhanced uptake and improved therapeutic efficacy in human retinal endothelial cells. Invest Ophthalmol Vis Sci. 2018;59:2119\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1866_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol. 2016;23:253\u20139.","journal-title":"Curr Opin Hematol"},{"key":"1866_CR24","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1167\/iovs.14-14409","volume":"56","author":"R Tian","year":"2015","unstructured":"Tian R, Liu Z, Zhang H, Fang X, Wang C, Qi S, et al. Investigation of the regulation of roundabout4 by hypoxia-inducible factor-1\u03b1 in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2015;56:2586\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1866_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12886-018-0697-2","volume":"18","author":"L Wen","year":"2018","unstructured":"Wen L, Wen YC, Ke GJ, Sun SQ, Dong K, Wang L, et al. TRPV4 regulates migration and tube formation of human retinal capillary endothelial cells. BMC Ophthalmol. 2018;18:38.","journal-title":"BMC Ophthalmol"},{"key":"1866_CR26","doi-asserted-by":"publisher","first-page":"e0129383","DOI":"10.1371\/journal.pone.0129383","volume":"10","author":"L Pertl","year":"2015","unstructured":"Pertl L, Steinwender G, Mayer C, Hausberger S, P\u00f6schl EM, Wackernagel W, et al. A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PLoS One. 2015;10:e0129383.","journal-title":"PLoS One"},{"key":"1866_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fphar.2017.00146","volume":"8","author":"S Immenschuh","year":"2017","unstructured":"Immenschuh S, Vijayan V, Janciauskiene S, Gueler F. Heme as a target for therapeutic interventions. Front Pharmacol. 2017;8:146.","journal-title":"Front Pharmacol"},{"key":"1866_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2018.08.005","volume":"133","author":"RK Donegan","year":"2019","unstructured":"Donegan RK, Moore CM, Hanna DA, Reddi AR. Handling heme: the mechanisms underlying the movement of heme within and between cells. Free Radic Biol Med. 2019;133:88\u2013100.","journal-title":"Free Radic Biol Med"},{"key":"1866_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.molmed.2016.01.004","volume":"22","author":"LT Roumenina","year":"2016","unstructured":"Roumenina LT, Rayes J, Lacroix-Desmazes S, Dimitrov JD. Heme: modulator of plasma systems in hemolytic diseases. Trends Mol Med. 2016;22:200\u201313.","journal-title":"Trends Mol Med"},{"key":"1866_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.preteyeres.2017.11.002","volume":"64","author":"JS Joyal","year":"2018","unstructured":"Joyal JS, Gantner ML, Smith LEH. Retinal energy demands control vascular supply of the retina in development and disease: the role of neuronal lipid and glucose metabolism. Prog Retin Eye Res. 2018;64:131\u201356.","journal-title":"Prog Retin Eye Res"},{"key":"1866_CR31","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1172\/JCI42142","volume":"120","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120:3022\u201332.","journal-title":"J Clin Invest"},{"key":"1866_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.exer.2008.09.004","volume":"87","author":"ME Pennesi","year":"2008","unstructured":"Pennesi ME, Nishikawa S, Matthes MT, Yasumura D, LaVail MM. The relationship of photoreceptor degeneration to retinal vascular development and loss in mutant rhodopsin transgenic and RCS rats. Exp Eye Res. 2008;87:561\u201370.","journal-title":"Exp Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-021-01866-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T17:12:04Z","timestamp":1724519524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01866-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01866-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-61500\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}